Carlon Burt, MBA
About Carlon Burt, MBA
Carlon Burt, MBA, is the Oncology Regional Business Director for West US at Bristol-Myers Squibb, with extensive experience in the pharmaceutical industry and a strong track record in leading high-performing teams.
Company
Carlon Burt is currently employed at Bristol-Myers Squibb, where he serves as the Oncology Regional Business Director for the West US. He has a long-standing tenure with the company, having held various roles since joining.
Title
Carlon Burt holds the position of Oncology Regional Business Director for the West US at Bristol-Myers Squibb. In this role, he oversees oncology operations and ensures alignment with the company's business strategies.
Education and Expertise
Carlon Burt earned his MBA from the University of Minnesota's Carlson School of Management, completing his studies from 2011 to 2013. He also holds a BA in Journalism, Communication & African-American Studies from the University of Minnesota-Twin Cities, which he completed in 1992. He has extensive knowledge in the oncology market, along with over a decade of experience in leading high-performing teams and developing talent.
Background
Carlon Burt's professional journey includes significant roles at several major companies. Prior to his current role, he served as Associate Director and Manager of US Oncology Field Force Learning & Development at Bristol-Myers Squibb. He also worked at GlaxoSmithKline in various capacities, including Senior District Sales Manager and Executive Therapeutic Specialist. Additionally, he has held roles at Abbott Nutrition and MIDWEST COCA-COLA, INC.
Achievements
In 2020, under Carlon Burt's leadership, the West US region at Bristol-Myers Squibb achieved the top ranking in Oncology among six regions. Additionally, three districts under his supervision ranked in the top ten percent nationally. He also won the 'Ours to Own' seven-month national Lung contest. His strategic initiatives and relationship-building with key healthcare contacts have consistently driven superior business results.